Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 2Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Sarcoma 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma 8Liposarcoma 8Hemangiosarcoma 8Fibrosarcoma 8Lymphoma, Large B-Cell, Diffuse 7Sarcoma, Synovial 6Rhabdomyosarcoma 6Neurofibrosarcoma 6Malignant mesenchymal tumor 6Leukemia 6Leiomyosarcoma 6Histiocytoma, Malignant Fibrous 6Hemangiopericytoma, Malignant 6Testicular Neoplasms 5Teratoma 5Neuroectodermal Tumors, Primitive, Peripheral 5Lung Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Testicular Germ Cell Tumor 4Ovarian Neoplasms 4Lymphoma, Non-Hodgkin 4Endodermal Sinus Tumor 4Seminoma 3Neuroblastoma 3Neoplasm Metastasis 3Lymphoma, Follicular 3Hodgkin Disease 3Carcinoma, Embryonal 3

Interventions

Etoposide 34Carboplatin 31Topotecan 24Cisplatin 21atezolizumab 11PM 01183 8durvalumab 7Irinotecan 7amrubicin 5PE regimen 4AMG 757 4rovalpituzumab tesirine 3pembrolizumab 3Magnetic Resonance Spectroscopy 3Dexamethasone 3tremelimumab 2tislelizumab 2etoposide phosphate 2apatinib 2Vitamin E 2Tiragolumab 2Specimen Handling 2Radiosurgery 2RRx-001 2Paclitaxel 2Memantine 2Injections 2EC regimen 2trilaciclib 1toripalimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Small Cell Lung Carcinoma × Ifosfamide × Clear all
NCT00658580 2015-02-12

Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer

European Lung Cancer Working Party

Phase 3 Completed
361 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡